Cargando…

Exploring the Diagnostic Potential of Serum Golgi Protein 73 for Hepatic Necroinflammation and Fibrosis in Chronic HCV Infection with Different Stages of Liver Injuries

BACKGROUND AND AIM: Serum Golgi protein 73 (GP73) is a promising alternative biomarker of chronic liver diseases, but most data are from patients with HBV infection rather than HCV. MATERIALS AND METHODS: Two independent cohorts of chronic hepatitis C (CHC) patients from the 5th Medical Centre of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Xiangjun, Zheng, Sujun, Wang, Leijie, Yao, Mingjie, Guan, Guiwen, Wen, Xiajie, Zhang, Ling, Xu, Qiang, Chen, Xiangmei, Zhao, Jingmin, Duan, Zhongping, Lu, Fengmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766121/ https://www.ncbi.nlm.nih.gov/pubmed/31636735 http://dx.doi.org/10.1155/2019/3862024

Ejemplares similares

Serum Golgi Protein 73 as a Potential Biomarker for Hepatic Necroinflammation in Population with Nonalcoholic Steatohepatitis
por: Wang, Leijie, et al.
Publicado: (2020)

Deoxycholic Acid Upregulates Serum Golgi Protein 73 through Activating NF-κB Pathway and Destroying Golgi Structure in Liver Disease
por: Yang, Danli, et al.
Publicado: (2021)

Diagnostic Value of Serum Golgi Protein 73 for Liver Inflammation in Patients with Autoimmune Hepatitis and Primary Biliary Cholangitis
por: Yao, Mingjie, et al.
Publicado: (2022)

Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma
por: Liu, Tianhui, et al.
Publicado: (2017)

Relationship between the Level of Serum Golgi Protein 73 and the Risk of Short-term Death in Patients with ALD-ACLF
por: Tong, Jingjing, et al.
Publicado: (2022)

Liver Stiffness Measurement Can Reflect the Active Liver Necroinflammation in Population with Chronic Liver Disease: A Real-world Evidence Study
por: Wang, Leijie, et al.
Publicado: (2019)

Use of serum Golgi protein 73 for screening chronic hepatitis B virus infection patients needing antiviral therapy in the community
por: Duan, Jinwei, et al.
Publicado: (2022)

Association between serum sphingolipids and necroinflammation of liver tissue pathology in chronic hepatitis B
por: Ren, Yan, et al.
Publicado: (2022)

M2-like macrophages exert hepatoprotection in acute-on-chronic liver failure through inhibiting necroptosis-S100A9-necroinflammation axis
por: Bai, Li, et al.
Publicado: (2021)

Serum Golgi protein 73 is a marker comparable to APRI for diagnosing significant fibrosis in children with liver disease
por: Liu, Langli, et al.
Publicado: (2018)

Death and fire—the concept of necroinflammation
por: Linkermann, Andreas
Publicado: (2018)

Integration of Prealbumin into Child-Pugh Classification Improves Prognosis Predicting Accuracy in HCC Patients Considering Curative Surgery
por: Wen, Xiajie, et al.
Publicado: (2018)

Circulating MiRNA-122 Levels Are Associated with Hepatic Necroinflammation and Portal Hypertension in HIV/HCV Coinfection
por: Jansen, Christian, et al.
Publicado: (2015)

Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients
por: Sagnelli, Caterina, et al.
Publicado: (2017)

Neonatal obstructive nephropathy induces necroptosis and necroinflammation
por: Popper, Bastian, et al.
Publicado: (2019)

Elevated apolipoprotein B predicts poor postsurgery prognosis in patients with hepatocellular carcinoma
por: Yan, Xiaotong, et al.
Publicado: (2019)

Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19
por: Tomar, Bhawna, et al.
Publicado: (2020)

Types of necroinflammation, the effect of cell death modalities on sterile inflammation
por: Mázló, Anett, et al.
Publicado: (2022)

Genetic disruption of NRF2 promotes the development of necroinflammation and liver fibrosis in a mouse model of HFE-hereditary hemochromatosis
por: Duarte, Tiago L., et al.
Publicado: (2016)

Dapagliflozin Alleviates Renal Fibrosis by Inhibiting RIP1-RIP3-MLKL-Mediated Necroinflammation in Unilateral Ureteral Obstruction
por: Xuan, Mei Ying, et al.
Publicado: (2022)

RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD
por: Chen, Hui, et al.
Publicado: (2018)

RNA binding protein TIAR modulates HBV replication by tipping the balance of pgRNA translation
por: Zhang, Ting, et al.
Publicado: (2023)

Association between serum S100A9 levels and liver necroinflammation in chronic hepatitis B
por: Wu, Rui, et al.
Publicado: (2018)

Discordance between Liver Biopsy and FibroScan® in Assessing Liver Fibrosis in Chronic Hepatitis B: Risk Factors and Influence of Necroinflammation
por: Kim, Seung Up, et al.
Publicado: (2012)

Cell type-specific roles of NLRP3, inflammasome-dependent and -independent, in host defense, sterile necroinflammation, tissue repair, and fibrosis
por: Honda, Tamisa Seeko Bandeira, et al.
Publicado: (2023)

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
por: Long, Lu, et al.
Publicado: (2014)

Golgi protein 73 and its diagnostic value in liver diseases
por: Xia, Yanyan, et al.
Publicado: (2018)

Golgi protein 73, hepatocellular carcinoma and other types of cancers
por: Wang, Yanan, et al.
Publicado: (2020)

Golgi Phosphoprotein 73: The Driver of Epithelial-Mesenchymal Transition in Cancer
por: Liu, Yiming, et al.
Publicado: (2021)

Golgi-protein 73 facilitates vimentin polymerization in hepatocellular carcinoma
por: Hu, Xinyang, et al.
Publicado: (2023)

Factors associated with significant liver necroinflammation in chronic hepatitis B patients with cirrhosis
por: Chen, Sheng-Sen, et al.
Publicado: (2016)

A Higher Correlation of HCV Core Antigen with CD4+ T Cell Counts Compared with HCV RNA in HCV/HIV-1 Coinfected Patients
por: Shen, Tao, et al.
Publicado: (2011)

GP73 Is Upregulated by Hepatitis C Virus (HCV) Infection and Enhances HCV Secretion
por: Hu, Longbo, et al.
Publicado: (2014)

Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma
por: Yao, Mingjie, et al.
Publicado: (2016)

Serum Golgi Protein 73 (GP73) is a Diagnostic and Prognostic Marker of Chronic HBV Liver Disease
por: Xu, Zhengju, et al.
Publicado: (2015)

Golgi Protein 73 (GP73) Serum Levels Predict Outcome after Resection of Biliary Tract Cancer
por: Loosen, Sven H., et al.
Publicado: (2022)

A meta-analysis of the prognostic impact of tissue golgi protein 73 (tGP73) in hepatocellular carcinoma
por: Yu, Wei-Ming, et al.
Publicado: (2023)

Reappraisal of the diagnostic value of alpha‐fetoprotein for surveillance of HBV‐related hepatocellular carcinoma in the era of antiviral therapy
por: Qian, Xiangjun, et al.
Publicado: (2020)

Application of serum Golgi protein-73 in the management of chronic liver disease
por: Yao, Ming-Jie, et al.
Publicado: (2021)

Identification of circulating microRNAs as potential biomarkers for hepatic necroinflammation in patients with autoimmune hepatitis
por: Saeki, Chisato, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s8qufas63loafrel1qqbk2umsv